SUPN - Supernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55 revenue of $153.8M beats by $14.78M
2023-05-09 16:20:35 ET
- Supernus Pharmaceuticals press release ( NASDAQ: SUPN ): Q1 GAAP EPS of $0.29 beats by $0.55 .
- Revenue of $153.8M (+0.8% Y/Y) beats by $14.78M .
- FY23 Total revenues to be $580M - $620M, vs. $599.79M consensus.
For further details see:
Supernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55, revenue of $153.8M beats by $14.78M